Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric Hypoglycemia

NCT02771574 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Post Bariatric Hypoglycemia

Interventions

DRUG: Lyo avexitide
DRUG: Liq avexitide

Sponsor

Tracey McLaughlin

Collaborators

[object Object]